CDEK
← All organizations

Mycovia Pharmaceuticals Inc.

For profitContributed to NMEWebsite ↗

Also known as: Mycovia Pharmaceuticals Inc. | MYCOVIA PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Aug 16, 2018

First marketed drug

Apr 26, 2022

First NDA

Apr 26, 2022

Last known activity

Apr 26, 2022

Timeline

2010s

  1. Jun 1, 2018

    Mycovia Pharmaceuticals Inc.— Founded

2020s

  1. Apr 26, 2022

    oteseconazole— Marketing Organization

  2. Apr 26, 2022

    oteseconazole— NDA Organization

  3. Apr 26, 2022

    oteseconazole— NDA Secondary Org

Drugs by trial phase (2 distinct, 3 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (3)

Details

Founded
Durham, NC, US Jun 1, 2018
First NDA
Apr 26, 2022
Last known activity
Apr 26, 2022

Designations held

  • Fast track
  • Priority review